BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rashid M, Zadeh LR, Baradaran B, Molavi O, Ghesmati Z, Sabzichi M, Ramezani F. Up-down regulation of HIF-1α in cancer progression. Gene 2021;798:145796. [PMID: 34175393 DOI: 10.1016/j.gene.2021.145796] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Ouyang C, Zhang J, Lei X, Xie Z, Liu X, Li Y, Huang S, Wang Z, Tang G. Advances in antitumor research of HIF-1α inhibitor YC-1 and its derivatives. Bioorg Chem 2023;133:106400. [PMID: 36739684 DOI: 10.1016/j.bioorg.2023.106400] [Reference Citation Analysis]
2 Xu Z, Yu Z, Li S, Tian Z, Yuan J, You F. Exploration of the core gene signatures and mechanisms between NAFLD and sarcopenia through transcriptomic level. Front Endocrinol 2023;14. [DOI: 10.3389/fendo.2023.1140804] [Reference Citation Analysis]
3 Wu Y, Wan X, Shao Y, Wang W, Huang W, Zhu J, Jiang L. Rhaponticin suppresses the hypoxia-induced factor-1 alpha-mediated aggressive phenotype of tongue squamous cell carcinoma. Mol Cell Toxicol 2023. [DOI: 10.1007/s13273-023-00337-2] [Reference Citation Analysis]
4 Toska A, Modi N, Chen LF. RUNX3 Meets the Ubiquitin-Proteasome System in Cancer. Cells 2023;12. [PMID: 36899853 DOI: 10.3390/cells12050717] [Reference Citation Analysis]
5 Wang X, Zhang N, Li M, Hong T, Meng W, Ouyang T. Ubiquitin C‑terminal hydrolase‑L1: A new cancer marker and therapeutic target with dual effects (Review). Oncol Lett 2023;25:123. [PMID: 36844618 DOI: 10.3892/ol.2023.13709] [Reference Citation Analysis]
6 Kang C, Ju S, Kim J, Jung Y. Chloroquine prevents hypoxic accumulation of HIF-1α by inhibiting ATR kinase: implication in chloroquine-mediated chemosensitization of colon carcinoma cells under hypoxia. Pharmacol Rep 2023;75:211-21. [PMID: 36508076 DOI: 10.1007/s43440-022-00441-5] [Reference Citation Analysis]
7 Wang M, Wang D, Lang Y, Shao A, Zhang R, Tang J, Lai D, Xiao C. L3MBTL3 is induced by HIF-1α and fine tunes the HIF-1α degradation under hypoxia in vitro. Heliyon 2023;9:e13222. [PMID: 36747531 DOI: 10.1016/j.heliyon.2023.e13222] [Reference Citation Analysis]
8 Xu Y, Ren B, Wang M. HIF-1α contributes to metastasis in choriocarcinoma by regulating DEC1 expression. Clin Transl Oncol 2022. [PMID: 36575343 DOI: 10.1007/s12094-022-03055-8] [Reference Citation Analysis]
9 Liang B, Deng L, Zhou X. Targeting hypoxia-related metabolism molecules: How to improve tumour immune and clinical treatment? Biomedicine & Pharmacotherapy 2022;156:113917. [DOI: 10.1016/j.biopha.2022.113917] [Reference Citation Analysis]
10 Christodoulou P, Kyriakou TC, Boutsikos P, Andreou M, Ji Y, Xu D, Papageorgis P, Christodoulou MI. Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. Biomedicines 2022;10. [PMID: 36551790 DOI: 10.3390/biomedicines10123037] [Reference Citation Analysis]
11 Rašková M, Lacina L, Kejík Z, Venhauerová A, Skaličková M, Kolář M, Jakubek M, Rosel D, Smetana K Jr, Brábek J. The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities. Cells 2022;11. [PMID: 36429126 DOI: 10.3390/cells11223698] [Reference Citation Analysis]
12 Wang C, Kadigamuwa C, Wu S, Gao Y, Chen W, Gu Y, Wang S, Li X. RNA N6-Methyladenosine (m6A) Methyltransferase-like 3 Facilitates Tumorigenesis and Cisplatin Resistance of Arecoline-Exposed Oral Carcinoma. Cells 2022;11. [PMID: 36429032 DOI: 10.3390/cells11223605] [Reference Citation Analysis]
13 Pachane BC, Nunes ACC, Cataldi TR, Micocci KC, Moreira BC, Labate CA, Selistre-de-Araujo HS, Altei WF. Small Extracellular Vesicles from Hypoxic Triple-Negative Breast Cancer Cells Induce Oxygen-Dependent Cell Invasion. Int J Mol Sci 2022;23. [PMID: 36293503 DOI: 10.3390/ijms232012646] [Reference Citation Analysis]
14 Cheng W, Xiao X, Liao Y, Cao Q, Wang C, Li X, Jia Y. Conducive target range of breast cancer: Hypoxic tumor microenvironment. Front Oncol 2022;12:978276. [DOI: 10.3389/fonc.2022.978276] [Reference Citation Analysis]
15 Li L, Ma H, Li D, Shu Q, Wang T, Song X, Xu H. Myricetin alleviates the formaldehyde-enhanced Warburg effect in tumor cells through inhibition of HIF-1α. Toxicol Appl Pharmacol 2022;454:116246. [PMID: 36116563 DOI: 10.1016/j.taap.2022.116246] [Reference Citation Analysis]
16 Han H, Lee S, Xu Y, Kim J, Lee H. SPHK/HIF-1α Signaling Pathway Has a Critical Role in Chrysin-Induced Anticancer Activity in Hypoxia-Induced PC-3 Cells. Cells 2022;11:2787. [DOI: 10.3390/cells11182787] [Reference Citation Analysis]
17 Huang YJ, Chen YT, Huang CM, Kuo SH, Liao YY, Jhang WY, Wang SH, Ke CC, Huang YH, Cheng CM, Huang MY, Chuang CH. HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer. Cancers (Basel) 2022;14. [PMID: 36011045 DOI: 10.3390/cancers14164053] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Feng Z, Ou Y, Hao L. The roles of glycolysis in osteosarcoma. Front Pharmacol 2022;13:950886. [DOI: 10.3389/fphar.2022.950886] [Reference Citation Analysis]
19 Wang Z, Mu X, Yang Q, Luo J, Zhao Y. Hypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha. J Colloid Interface Sci 2022;628:106-15. [PMID: 35987150 DOI: 10.1016/j.jcis.2022.08.060] [Reference Citation Analysis]
20 Li J, Zhang Y, Luo B. Effects of Exosomal Viral Components on the Tumor Microenvironment. Cancers 2022;14:3552. [DOI: 10.3390/cancers14143552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kim M, Cho Y, Kim E, Choe J, Park J, Lee J, Lee J, Moon S, Kim Y, Kim S, Choi E. Cellular Prion Protein Is Closely Associated with Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma. Diagnostics 2022;12:1635. [DOI: 10.3390/diagnostics12071635] [Reference Citation Analysis]
22 Belogubov PV, Ruzov VI, Slesarev SM, Sharafutdinova RR. ALCOHOL-INDUCED EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND STRUCTURAL CHANGES IN RAT CARDIOMYOCYTES. Ulyanovsk Medico-biological Journal 2022. [DOI: 10.34014/2227-1848-2022-2-102-116] [Reference Citation Analysis]
23 Wang Z, Guan Q, Zhou H, Mao X, Chen F. Mechanistic insight into lysyl oxidase in vascular remodeling and angiogenesis. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.05.011] [Reference Citation Analysis]
24 Yan Q, Sun Y, An R, Liu F, Fang Q, Wang Z, Xu T, Chen L, Du J. Application and progress of the detection technologies in hepatocellular carcinoma. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.04.003] [Reference Citation Analysis]
25 Zalpoor H, Bakhtiyari M, Liaghat M, Nabi-Afjadi M, Ganjalikhani-Hakemi M. Quercetin potential effects against SARS-CoV-2 infection and COVID-19-associated cancer progression by inhibiting mTOR and hypoxia-inducible factor-1α (HIF-1α). Phytother Res 2022. [PMID: 35307904 DOI: 10.1002/ptr.7440] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
26 Li Y, Li S, Wu H. Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress. Cells 2022;11:851. [PMID: 35269473 DOI: 10.3390/cells11050851] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
27 Wu Y, Lu M, Lin T, Chu P, Chang C. Synthesis and Evaluation of Biarylquinoline Derivatives as Novel HIF-1α Inhibitors. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105681] [Reference Citation Analysis]
28 Choromańska B, Myśliwiec P, Kozłowski T, Łuba M, Wojskowicz P, Dadan J, Myśliwiec H, Choromańska K, Makarewicz K, Zalewska A, Maciejczyk M. Cross-Talk Between Nitrosative Stress, Inflammation and Hypoxia-Inducible Factor in Patients with Adrenal Masses. J Inflamm Res 2021;14:6317-30. [PMID: 34876829 DOI: 10.2147/JIR.S337910] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]